Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Annals of the Rheumatic Diseases|August 8, 2025
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitisPeter A Merkel, Parameswaran K Nair, Nader Khalidi, et al.
Plos One|November 20, 2014
A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCAAna Márquez, Roser Solans, José Hernández-Rodríguez, et al.
Annals of the Rheumatic Diseases|September 1, 2010
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trialMarco Matucci-Cerinic, Christopher P Denton, Daniel E Furst, et al.
Nature Reviews. Rheumatology|September 15, 2017
Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitisXavier Bossuyt, Jan-Willem Cohen Tervaert, Yoshihiro Arimura, et al.
Annals of the Rheumatic Diseases|July 5, 2019
2018 Update of the EULAR recommendations for the management of large vessel vasculitisBernhard Hellmich, Ana Agueda, Sara Monti, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Clinical and Experimental Rheumatology|April 29, 2024
The Joint Vasculitis Registry in German-speaking countries (GeVas): subgroup analysis of 195 GCA patientsPia Wallmeier, Sabrina Arnold, Arlette Tais, et al.
Annals of the Rheumatic Diseases|March 17, 2023
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateBernhard Hellmich, Beatriz Sanchez-Alamo, Jan H Schirmer, et al.
Nature Reviews. Rheumatology|May 10, 2023
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitisGiacomo Emmi, Alessandra Bettiol, Elena Gelain, et al.
Pageof 16